Apotea AB (APOTEA)

Currency in SEK
100.40
+0.60(+0.60%)
Closed·
APOTEA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
98.75100.90
52 wk Range
54.42107.20
Key Statistics
Prev. Close
100.4
Open
99
Day's Range
98.75-100.9
52 wk Range
54.42-107.2
Volume
209.2K
Average Volume (3m)
241.21K
1-Year Change
14.1428%
Book Value / Share
9.91
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
APOTEA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
105.50
Upside
+5.08%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Apotea AB News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 105.50
(+5.08% Upside)

Apotea AB Earnings Call Summary for Q2/2026

  • Apotea Q2 revenue rose 10.9% YoY to SEK 2,026M, topping forecast; adjusted EBIT margin held steady at 5.2%, shares surged 8.21% in pre-market.
  • New Varberg fulfillment center now processes 30,000+ daily orders; inventory climbed to SEK 850M, pressuring cash flow amid operational ramp-up.
  • Company launched apotea.no in Norway with gradual marketing rollout; management eyes long-term expansion in new market despite early-stage uncertainty.
  • CEO Svärdson projects 'single-digit %' quarterly growth improvements; annual capex expected at SEK 50-70M as firm optimizes fulfillment operations.
  • Rolling 12-month revenue neared SEK 7.6B with 4.2% adjusted EBIT margin; analysts note stock trades 34.7% below 52-week high, citing upside potential.
Last Updated: 2026-07-17, 04:02 a/m
Read Full Transcript

Earnings

Latest Release
Nov 05, 2026
EPS / Forecast
0.79 / 0.71
Revenue / Forecast
1.99B / 1.98B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.49
Dividend Yield
0.60%
Industry Median 3.29%
Annualized payout
0.60
Paid annually
5-Years Growth
-
Growth Streak

APOTEA Income Statement

Compare APOTEA to Peers and Sector

Metrics to compare
APOTEA
Peers
Sector
Relationship
P/E Ratio
40.4x12.1x10.7x
PEG Ratio
0.580.080.03
Price/Book
10.1x1.7x1.5x
Price / LTM Sales
1.3x2.0x0.8x
Upside (Analyst Target)
5.1%−5.7%22.6%
Fair Value Upside
Unlock9.8%13.8%Unlock

Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, baby, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements. It also provides products in the categories of body care, stomach and intestine, food and drink, mouth and teeth, premium, trip, sex and lust, stop smoking, makeup, sun protection, wounds and injuries, sleep and sleep problems, training, weight control, vitamins and minerals, charity, and eyes and ears. In addition, the company offers leasing and hiring out personnel to related companies, as well as marketing contributions. The company was founded in 2011 and is headquartered in Stockholm, Sweden.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
17.86M17.16%1.79B
Other Institutional Investors
54.64M52.50%5.49B
Public Companies & Retail Investors
31.58M30.34%3.17B
Total
104.07M100.00%10.45B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Laulima AB29.13%30,313,1353,043,439
Nordea Investment Management, AB10.29%10,712,5941,075,544

People Also Watch

306.00
SKAb
+0.23%
470.80
TRELb
-0.21%
165.70
TEL2b
+0.94%
284.0
AXFO
+1.83%
558.50
CLASb
+1.18%

FAQ

What Is the Apotea (APOTEA) Stock Price Today?

The Apotea stock price today is 100.40 SEK.

What Stock Exchange Does Apotea Trade On?

Apotea is listed and trades on the Stockholm Stock Exchange.

What Is the Stock Symbol for Apotea?

The stock symbol for Apotea is "APOTEA."

Does Apotea Pay Dividends? What’s The Current Dividend Yield?

The Apotea dividend yield is 0.6%%.

What Is the Apotea Market Cap?

As of today, Apotea market cap is 10.45B SEK.

What Is Apotea's Earnings Per Share (TTM)?

The Apotea EPS (TTM) is 2.49.

When Is the Next Apotea Earnings Date?

Apotea will release its next earnings report on Feb 04, 2027.

From a Technical Analysis Perspective, Is APOTEA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Apotea Stock Split?

Apotea has split 0 times.

How Many Employees Does Apotea Have?

Apotea has 736 employees.

What is the current trading status of Apotea (APOTEA)?

As of Nov 16, 2026, Apotea (APOTEA) is trading at a price of 100.40 SEK, with a previous close of 100.40 SEK. The stock has fluctuated within a day range of 98.75 SEK to 100.90 SEK, while its 52-week range spans from 54.42 SEK to 107.20 SEK.

What Is Apotea (APOTEA) Price Target According to Analysts?

The average 12-month price target for Apotea is 105.50 SEK, with a high estimate of 114 SEK and a low estimate of 97 SEK. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +5.08% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.